Los Angeles Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	BUY	$13.58 - $17.36 $251,148 - $321,055	18,494 New	18,494 $290,000
Q2 2023 Aug 03, 2023	SELL	$13.28 - $15.96 $62,190 - $74,740	-4,683 Reduced 25.85%	13,435 $189,000
Q1 2023 May 04, 2023	BUY	$14.26 - $22.1 $258,362 - $400,407	18,118 New	18,118 $279,000
Q2 2022 Aug 05, 2022	BUY	$9.11 - $13.98 $3,552 - $5,452	390 Added 3.69%	10,970 $144,000
Q1 2022 May 06, 2022	BUY	$6.87 - $11.11 $72,684 - $117,543	10,580 New	10,580 $98,000
Q2 2021 Aug 05, 2021	SELL	$32.73 - $47.95 $264,294 - $387,196	-8,075 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$40.39 - $56.73 $184,420 - $259,029	-4,566 Reduced 36.12%	8,075 $362,000
Q4 2020 Feb 04, 2021	BUY	$51.77 - $66.18 $19,672 - $25,148	380 Added 3.1%	12,641 $721,000
Q3 2020 Nov 02, 2020	BUY	$43.8 - $58.16 $355,218 - $471,677	8,110 Added 195.37%	12,261 $629,000
Q2 2020 Aug 05, 2020	BUY	$37.05 - $65.03 $153,794 - $269,939	4,151 New	4,151 $247,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.